Takeda submits NDA for hypertension drug in US
Discovered by Takeda, the compound is indicated for the treatment of hypertension, or high blood pressure. Azilsartan medoxomil is an angiotensin II receptor blocker (ARB) which lowers blood
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
euSEND brings together universities, pharma firms, other international research organizations and product development partnerships to encourage development of solutions for neglected tropical diseases. The Dutch initiative builds, amongst